Filter
480
Filtered Results: 480
Text search:
in
vitro
diagnostic
tests
Featured
Recommendations
67
New Publications
100
Language
Document type
No document type
218
Guidelines
126
Studies & Reports
57
Manuals
43
Fact sheets
14
Strategic & Response Plan
13
Training Material
5
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
24
Germany
15
Global
12
South Africa
11
Latin America and the Carribbean
11
Africa
10
Western and Central Europe
8
Russia
7
Ethiopia
5
Kenya
5
Tanzania
5
Rwanda
5
Nigeria
4
Cameroon
4
Namibia
4
Brazil
4
Eastern Europe
4
Burkina Faso
3
Uganda
3
Zambia
3
West and Central Africa
3
Congo-Brazzaville
3
Sierra Leone
2
Senegal
2
Congo, Democratic Republic of
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Niger
2
Haiti
2
Nepal
2
Bangladesh
2
Malawi
2
Benin
2
Argentina
2
Eswatini/ Swaziland
2
Ukraine
2
Madagascar
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Asia
2
Venezuela
2
France
2
Guinea
1
Liberia
1
USA
1
Togo
1
Zimbabwe
1
Philippines
1
South Sudan
1
Turkey
1
Syria
1
Gambia
1
Indonesia
1
Peru
1
Burundi
1
Colombia
1
Bolivia
1
Angola
1
Chile
1
Yemen
1
South–East Asia Region
1
Luxembourg
1
Albania
1
Djibouti
1
Southern Africa
1
Laos
1
Canada
1
North America
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
109
Clinical Guidelines
107
Pharmacy & Technologies
40
Public Health
15
Women & Child Health
15
Key Resources
9
Toolboxes
TB
69
COVID-19
66
HIV
65
AMR
32
NTDs
29
Rapid Response
21
Pharmacy
16
Zika
12
Ebola
11
Refugee
10
Caregiver
8
Polio
6
Mental Health
3
Planetary Health
3
Cholera
2
Global Health Education
2
Natural Hazards
1
Specific Hazards
1
NCDs
1
Most of the global burden of sepsis occurs in low- and middle-income countries (LMICs), but the prevalence and etiology of sepsis in LMICs are not well understood. ... particular, the lack of laboratory infrastructure in many LMICs has historically precluded an assessment of the pathogens leading to sepsis. A recent systematic review found that data describing antimicrobial resistance were absent for 43% of countries in Africa, and only two countries have national antimicrobial resistance plans. In addition, small studies have identified indiscriminate antibiotic use both in and out of hospital settings in sub-Saharan Africa. The absence of microbiological data and lack of antibiotic stewardship complicate sepsis management and almost certainly worsens outcomes, particularly in low-resource systems. The purpose of this study was to examine the prevalence, etiology, and outcomes of sepsis among a cohort of critically ill patients in a referral hospital of Malawi, with a focus on the prevalence of culture-confirmed bacteremia and urinary tract infections.
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0190785 January 10, 2018
Prepared by NGOs: “Legalife-Ukraine”, “Insight”, “Positive Women”, and “Svitanok”
For the submission to the 66th CEDAW Session Geneva, Switzerland
13 February 2017 - 03 March 2017
The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include:
Community-based surveillance to detect symptomatic cases early for treatment and to avert viral transmission;
Sentinel surveillance ... high-risk populations to detect and track both presymptomatic and asymptomatic cases; and
Wastewater surveillance to monitor early environmental signs of virus transmission and identify communities where targeted interventions can be implemented to decrease transmission.
Methodological field approaches for scientists with a basic background in entomology to prepare and implement a yellow fever entomological assessment during outbreaks
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described ... the document:
Broad spectrum Pan-African polyvalent antivenoms: products that are intended for widespread utility throughout sub-Saharan Africa for treatment of envenoming irrespective of the species of snake causing a bite. Monovalent antivenoms for specific use cases: for products for a single species (or genus) of snake (e.g., boomslangs or carpet viper antivenoms).
Syndromic Pan-African polyvalent antivenoms for neurotoxic envenoming: products that are intended for treatment of envenoming by species whose venoms are neurotoxic. Syndromic Pan-African polyvalent antivenoms for non-neurotoxic envenoming: products for snakebite envenoming where the effects are largely haemorrhagic, necrotic or procoagulant.
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for ...
Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific
The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identifying national and reference laboratories capable o...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in... people infected with SARS-CoV-2. Currently, the WHO and the PAHO recommend the use of corticosteroids, tocilizumab, baricitinib, and casirivimab e imdevimab (the latter in seronegative COVID-19 patients) and propose the use of sotrovimab, casirivimab/imdevimab, and molnupiravir in patients with non-severe illness who are at high risk for complications
30th World AIDS Day Report
STAR Initiative, Unitaid and World Health Organization December 2018
Biology, Diagnosis and Treatment, Epidemiology and Prevention
Second Edition
AIDS Medicines and diagnostics services
July 2015
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with...
In this document, recommendations are provided on designing and implementing
a cross-sectional serosurvey using school-based sampling to estimate age-specific
DENV seroprevalence to inform a country’s national dengue vaccination program.
The...
In many countries neonatal tetanus is responsible for half of all neonatal deaths due to vaccine-preventable diseases and for almost 14% of al¡ infant deaths. It is estimated that in the 1970s more...
The guidelines presented in this document are designed to provide a useful resource for healthcare professionals involved in clinical case management. They were developed taking into consideration s...
